EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS

<em>The article presents a case report of severe juvenile rheumatoid arthritis with uveitis, refractory to treatment with classic immuno-suppressants and chimeric monoclonal antibodies to the tumor necrotizing factor ?. Successful administration of biological agent adalimumab was described: mo...

Full description

Bibliographic Details
Main Authors: A.O. Lisitsin, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, N.A. Karagulyan, O.L. Lomakina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/1212
_version_ 1827837846706192384
author A.O. Lisitsin
E.I. Alexeeva
S.I. Valieva
T.M. Bzarova
N.A. Karagulyan
O.L. Lomakina
author_facet A.O. Lisitsin
E.I. Alexeeva
S.I. Valieva
T.M. Bzarova
N.A. Karagulyan
O.L. Lomakina
author_sort A.O. Lisitsin
collection DOAJ
description <em>The article presents a case report of severe juvenile rheumatoid arthritis with uveitis, refractory to treatment with classic immuno-suppressants and chimeric monoclonal antibodies to the tumor necrotizing factor ?. Successful administration of biological agent adalimumab was described: morning joints stiffness and exudative lesions in affected joints was completely stopped up to the 4th week of treatment, the range of motions was increased significantly. Laboratory indices of disease activity (ESR, C-reactive protein in plasma) were normalized to 6th week. Treatment with adalimumab induced the development of remission of subacute bilateral uveitis.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rheumatoid arthritis, treatment, adalimumab.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2009;8(6):<em>151-157</em>)</em></span>
first_indexed 2024-03-12T06:55:01Z
format Article
id doaj.art-5edb5b2bc0bb4a5fb3cd3aec80d89e62
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T06:55:01Z
publishDate 2009-01-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-5edb5b2bc0bb4a5fb3cd3aec80d89e622023-09-03T00:06:58Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352009-01-01861511571213EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITISA.O. Lisitsin0E.I. Alexeeva1S.I. Valieva2T.M. Bzarova3N.A. Karagulyan4O.L. Lomakina5Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow<em>The article presents a case report of severe juvenile rheumatoid arthritis with uveitis, refractory to treatment with classic immuno-suppressants and chimeric monoclonal antibodies to the tumor necrotizing factor ?. Successful administration of biological agent adalimumab was described: morning joints stiffness and exudative lesions in affected joints was completely stopped up to the 4th week of treatment, the range of motions was increased significantly. Laboratory indices of disease activity (ESR, C-reactive protein in plasma) were normalized to 6th week. Treatment with adalimumab induced the development of remission of subacute bilateral uveitis.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rheumatoid arthritis, treatment, adalimumab.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — </em></em></em>Current Pediatrics. 2009;8(6):<em>151-157</em>)</em></span>http://vsp.spr-journal.ru:80/jour/article/view/1212
spellingShingle A.O. Lisitsin
E.I. Alexeeva
S.I. Valieva
T.M. Bzarova
N.A. Karagulyan
O.L. Lomakina
EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
Вопросы современной педиатрии
title EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
title_full EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
title_fullStr EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
title_full_unstemmed EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
title_short EXPERIENCE OF ADMINISTRATION OF HUMAN MONOCLONAL ANTIBODIES TO TNF IN PATIENT WITH JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
title_sort experience of administration of human monoclonal antibodies to tnf in patient with juvenile rheumatoid arthritis with uveitis
url http://vsp.spr-journal.ru:80/jour/article/view/1212
work_keys_str_mv AT aolisitsin experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis
AT eialexeeva experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis
AT sivalieva experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis
AT tmbzarova experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis
AT nakaragulyan experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis
AT ollomakina experienceofadministrationofhumanmonoclonalantibodiestotnfinpatientwithjuvenilerheumatoidarthritiswithuveitis